BioNTech to Acquire MAB Discoverys Antibody Generation Unit Building on SixYear Collaboration

BioNTech to Acquire MAB Discovery’s Antibody Generation Unit, Building on Six-Year Collaboration

BioNTech said today it agreed to acquire the operational antibody generation unit of MAB Discovery for an undisclosed price, in a deal that builds on two collaborations by the companies stretching back nearly six years. The acquisition also expands the top privately-held developer of RNA-based therapeutics further into monoclonal antibody (mAb) development, with new treatments […]

More From BioPortfolio on "BioNTech to Acquire MAB Discovery’s Antibody Generation Unit, Building on Six-Year Collaboration"